Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s EBIT?
- Revolution Medicines, Inc. (RVMD) reported EBIT of -$445.22M in Q1 2026.
- How has Revolution Medicines, Inc.'s EBIT changed year-over-year?
- Revolution Medicines, Inc.'s EBIT decreased by 84.9% year-over-year, from -$240.76M to -$445.22M.
- What is the long-term trend for Revolution Medicines, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s EBIT has grown at a 58.4% compound annual growth rate (CAGR), from -$188.01M to -$1.18B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Revolution Medicines, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude